Nitrate stimulated tilt table testing: A review of the literature

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 7 I, 2003, Pages 1528-1537

  Aerts, Arnaud J J ^a   Dendale, Paul ^a,b  

^a Sittard Geleen Heerlen   (Netherlands)

^b VIRGA JESSE HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC GMP; ISOPRENALINE; MIDODRINE; NEUROHORMONE; NITRATE; PAROXETINE;

ASYSTOLE; AUTONOMIC NERVOUS SYSTEM; BLOOD; BRADYCARDIA; CHEMICAL ANALYSIS; CLINICAL TRIAL; DIAGNOSTIC VALUE; DRUG FORMULATION; HEMODYNAMICS; HISTORY; HUMAN; LEG; PATHOPHYSIOLOGY; PRESSORECEPTOR; REPRODUCIBILITY; REVIEW; SMOOTH MUSCLE RELAXATION; SYNCOPE; SYSTOLIC BLOOD PRESSURE; TILT TABLE TEST; TILTING; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0037932666     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.t01-1-00222.x     Document Type: Review

References (64)

1. Kenny RA, Bayliss J, Ingram A, et al. Head-up tilt: A useful test for investigating unexplained syncope. Lancet 1986; 2:1352-1355.
2. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: A comprehensive literature review. Am J Med 1994; 97:78-88.
3. Leman RB, Clarke E, Gillette P. Significant complications can occur with isehemic heart disease and tilt table testing. PACE 1999; 22:675-677.
4. McIntosch SJ, Lawson J, Kenny RA. Intravenous cannulation alters the specificity of head-up tilt testing for vasovagal syncope in elderly patients. Age Ageing 1994; 23:317-319.
5. Raviele A, Gasparini G, Di Pede F, et al. Nitroglycerin infusion during upright tilt: A new test for the diagnosis of vasovagal syncope. Am Heart J 1994; 127:103-111.
6. Takase B, Uehata A, Nishioka T, et al. Different mechanisms of isoproterenol-induced and nitroglycerin-induced syncope during head-up tilt in patients with unexplained syncope: Important role of epinephrine in nitroglycerin-induced syncope. J Cardiovasc Electrophysiol 2001; 12:791-796.
7. Aerts A, Dendale P, Strobel G, et al. Intravenous nitrates for pharmacological stimulation in head-up tilt testing in patients with vasovagal syncope and healthy controls. PACE 1999; 22:1593-1598.
8. Aerts A, Dendale P, Strobel G, et al. Sublingual nitrates during head-up tilt testing for the diagnosis of vasovagal syncope. Am Heart J 1997; 133:504-507.
9. Ammirati F, Colivicchi F, Biffi A, et al. Head-up tilt testing potentiated with low-dose sublingual isosorbide dinitrate: A simplified time-saving approach for the evaluation of unexplained syncope. Am Heart J 1998; 135:671-676.
10. Bartoletti A, Gaggioli G, Menozzi C, et al. Head-up tilt testing with oral nitroglycerin. A randomized trial of the contribution of a drug-free phase and a nitroglycerin phase in the diagnosis of neurally mediated syncope. Europace 1999; 1:183-186.
11. Zeng C, Zhu Z, Hu W, et al. Value of sublingual isosorbide dinitrate before isoproterenol tilt test for diagnosis of neurally mediated syncope. Am J Cardiol 1999; 83:1059-1063.
12. Natale A, Sra J, Akhtar M, et al. Use of sublingual nitroglycerin during head-up tilt-table testing in patients > 60 years of age. Am J Cardiol 1998; 82:1210-1213.
13. Foglia-Manzillo G, Giada F, Beretta S, et al. Reproducibility of head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. Am J Cardiol 1999; 84:284-288.
14. Raviele A, Menozzi C, Brignole M, et al. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am I Cardiol 1995; 76:267-272.
15. Raviele A, Giada F, Brignole M, et al. Comparison of diagnostic accuracy of sublingual nitroglycerin test and low-dose isoproterenol test in patients with unexplained syncope. Am J Cardiol 2000; 85:1194-1198.
16. Oraii S, Maleki M, Minooii M, et al. Comparing two different protocols for tilt table testing: Sublingual glyceryl trinitrate versus isoprenaline infusion. Heart 1999; 81:603-605.
17. Kurbaan AS, Franzén AC, Bowker TJ, et al. Usefulness of tilt test-induced patterns of heart rate and blood pressure using a two-stage protocol with glyceryl trinitrate provocation in patients with syncope of unknown origin. Am J Cardiol 1999; 84:665-670.
18. Hermosillo AG, Marquez MF, Jauregui-Renaud K, et al. Tilt testing in neurocardiogenic syncope: Isosorbide versus isoproterenol. Acta Cardiol 2000; 55:351-355.
19. Graham LA, Gray JC, Kenny RA. Comparison of provocative tests for unexplained syncope: Isoprenaline and glyceryl trinitrate for diagnosing vasovagal syncope. Eur Heart J 2001; 22:497-503.
20. Del Rosso A, Bartoletti A, Bartoli P, et al. Methodology of head-up tilt testing potentiated with sublingual nitroglycerin in unexplained syncope. Am J Cardiol 2000; 85:1007-1011.
21. Zeng C, Liu G, Yang C, et al. Evaluation of a single stage nitroglycerin tilt table test for diagnosis of neurally mediated syncope. PACE 2001; 24:1494-1499.
22. Holubarsch Ch, Luscher T. In Ch Holubarsch, T Luscher (eds.): 120 Years of Nitrate Therapy. Berlin, New York, Walter de Gruyter, 2000, pp. 1-5.
23. Fung HL, Chung SJ, Bauer JA, et al. Biochemical mechanism of organic nitrate action. Am J Cardiol 1992; 70:4B-10B.
24. Lydakis C, Chaudary A, Lip G. The 'vasovagal effect' of nitrates: An under-recognised complication of nitrate use. Int J Clin Pract 1998; 52:418-421.
25. Weiss S, Wilkins RW, Haynes FW. The nature of circulatory collapse induced by sodium nitrite. J Clin Invest 1937; 16:73-84.
26. Weissler AM, Warren JV, Estes EH, et al. Vasodepressor syncope, factors influencing cardiac output. Circulation 1957; 15:875-882.
27. Lopez ML, Lambert CR, Pepine CJ. Pharmacology and mechanisms of action of nitroglycerin and long-acting nitrates. In Dz E Rezakovic, JS Alpert (eds.): Nitrate Therapy & Nitrate Tolerance; Current Concepts and Controversies. Basel, Switzerland, Karger, 1993, pp. 1-30.
28. Wortmann A, Herrmann I, Gohl K, et al. Cardiodynamic changes during passive tilt and acute nitrate therapy. Eur Heart J 1992; 13(Suppl. E):65-68.
29. Zweifler AJ Hansson L. Heart rate responses during treatment of hypertension with propanonol; The clinical usefulness of the nitroglycerin test. Clin Pharmacol Ther 1976; 19:403-409.
30. Noll G, Wenzel RR, de Marchi S, et al. Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Circulation 1997; 95:2286-2292.
31. Ma A, Long JP. Central noradrenergic activity is responsible for nitroglycerin-induced cardiovascular effects in the nucleus tractus solitarii. Brain Res 1991; 559:297-303.
32. Jardine DL, Melton IC, Crozier, et al. Neurohormonal response to head-up tilt and its role in vasovagal syncope. Am J Cardiol 1997; 97:1302-1306.
33. Parker JO, Parker JD. Neurohormonal activation during nitrate therapy: A possible mechanism for tolerance. Am J Cardiol 1992; 70:93B-7B.
34. Koole MAC, Aerts A, Praet J, et al. Venous pooling during nitrate stimulated tilt testing in patients with vasovagal syncope. Europace 2000; 2:343-345.
35. Benditt DG, Ferguson DW, Grubb BP, et al. ACC expert consensus document. Tilt table testing for assessing syncope. J Am Coll Cardiol 1996; 28:263-275.
36. Morrison RA, Wiegand UW, Jahnchen E, et al. Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual, and percutaneous dosing in angina. Clin Pharmacol Ther 1983; 33:747-756.
37. Schneeweiss A, Weiss M. The mechanism of action of nitrates at the cellular level. In A Schneeweiss, M Weiss (eds.): Advances in Nitrate Therapy. Berlin, Heidelberg, Springer-Verlag, 1988, pp. 30-34, 133-142.
38. Pimlott SJ, Addy M. A study into the mucosal absorption of isosorbide dinitrate at different intraoral sites. Oral Med 1985; 59:145-148.
39. Reynolds JEF. Cardiovascular Agents. In JEF Reynolds (ed.): Martindale The Extra Pharmacopoeia. 31st ed. London, Royal Pharmaceutical Society, 1996, pp. 874-875, 893-894.
40. Marchionni N, De Bari M, Ferrucci L, et al. Comparative study of time-course of hemodynamic effect of isosorbide dinitrate spray and sublingual tablets in patients with pulmonary congestion. Cardiovasc Drug Ther 1988; 2:529-532.
41. Armstrong PW, Armstrong JA, Marks GC, et al. Blood level after sublingual nitroglycerin. Circulation 1979; 59:585-588.
42. Saito M, Fukami K, Sumiyoshi T, et al. Effects of isosorbide dinitrate spray on central hemodynamics. Arzneim Forsch Drug Res 1984; 34:1-7.
43. Ducharme A, Dupuis J, McNicoll S, et al. Comparison of nitroglycerin lingual spray and sublingual tablet on time of onset and duration of brachial artery vasodilation in normal subjects. Am J Cardiol 1999; 84:952-952.
44. Brignole M, Alboni P, Benditt D, et al. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 2001; 2:1256-1306.
45. Aerts A, Dendale P, Block P. Influence of tilt duration on diagnostic value in sublingual nitrate stimulated head up tilt testing. (abstract) Acta Cardiol 1997; 1:586.
46. Del Rosso AD, Bartoli P, Bartoletti A, et al. Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. Am Heart J 1998; 135:564-570.
47. Sutton R, Petersen M, Brignole M, et al. Proposed classification for tilt induced vasovagal syncope. Eur J Cardiol Pacing Electrophysiol 1992; 3:180-183.
48. Klingenheben T, Winten G, Li Y, et al. Usefulness of a pretest-classification score system to predict results of tilt table testing in patients with syncope of unknown origin. (abstract) Eur Heart J 1996; 17:581.
49. Aerts A, Dendale P, Block P. Reproducibility of sublingual nitrate stimulated head-up tilt test in patients with vasovagal syncope and healthy volunteers. (abstract) Eur Heart J 1997; 18:197.
50. Moya A, Permanyer-Miralda G, Sagrista J, et al. Is there a role for tilt testing in the evaluation of treatment of vasovagal syncope? In JJ Blanc, D Benditt, R Sutton, (ed.): Neurally Mediated Syncope. Armonk, NY, Futura Publishing Co., Inc., 1996, pp. 107-111.
51. Prodger SH, Ayman D. Harmful effects of nitroglycerin. Am J Med Sci 1932; 184:480-491.
52. Nemerovski M, Shah PK. Syndrome of severe bradycardia and hypotension following sublingual nitroglycerin administration. Cardiology 1981; 67:180-189.
53. Come PC, Pitt B. Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction. Circulation 1976; 54:624-628.
54. Ruiz GA, Peralta A, Gonzalez-Zuelgaray J, et al. Evolution of patients with clinical neurocardiogenic (vasovagal) syncope not subjected to specific treatment. Am Heart J 1995; 130:345-350.
55. Benditt DG, Fahy GJ, Lurie KG, et al. Parmacotherapy of neurally mediated syncope. Circulation 1999; 100:1242-1248.
56. Sutton R. Is there an effective pharmacological treatment in the prevention of vasovagal syncope? Arch Mal Coeur 1996; 89:25-28.
57. Brignole M, Menozzi C, Gianfranchi L, et al. A controlled trial of acute and long-term medical therapy in tilt induced neurally mediated syncope. Am J Cardiol 1992; 70:339-342.
58. Calkins H. Pharmacologic approaches to therapy for vasovagal syncope. Am J Cardiol 1999; 84:20Q-25Q.
59. Di Girolamo E, Di Iorio C, Sabatini P, et al. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope. J Am Coll Cardiol 1999; 33:1227-1230.
60. Perez-Lugones A, Schweikert R, Pavia S. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope. J Cardiovasc Electrophysiol 2001; 12:935-938.
61. Raviele A, Brignole M, Sutton R, et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: A double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 1999; 99:1452-1457.
62. Sutton R, Brignole M, Menozzi C, et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: A multicenter randomized study. Circulation 2000; 102:294-299.
63. Connolly SJ, Sheldon R, Roberts RS, et al. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coil Cardiol 1999; 33:16-20.
64. Benditt DG. Cardiac pacing for prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33:21-23.